Literature DB >> 18776820

Interpretation of repeat tuberculin skin testing in international adoptees: conversions or boosting.

Anna M Mandalakas1, H Lester Kirchner, Xaiobei Zhu, Kee Thai Yeo, Jeffrey R Starke.   

Abstract

BACKGROUND: Internationally-adopted children are a unique group of Bacille Calmette-Guérin (BCG)-vaccinated children with high rates of latent tuberculosis infection (LTBI) in whom serial tuberculin skin tests (TST) are recommended. No study has measured the incidence of TST conversion in these children.
METHODS: Internationally-adopted children completed baseline and follow-up TST to measure the incidence of Mycobacterium tuberculosis infection and factors associated with TST conversion. Data were collected regarding age, gender, birth country, vaccination history, history of tuberculosis (TB) exposure, previous TB screening, and preadoptive environment. All children completed physical examinations including a standardized evaluation for TB, anthropometric assessment, and documentation of BCG scar.
RESULTS: Fourteen percent of children (N = 390) had evidence of LTBI at baseline. Children were more likely to have LTBI if they were older, BCG vaccinated, or had been in the United States longer. An additional 13% of children had TST indurations > or = 10 mm at follow-up testing. Regardless of BCG vaccination status or nutritional status, children who were younger at baseline were more likely to have a TST induration > or = 10 mm at follow-up.
CONCLUSIONS: International adoptees have significant risk of LTBI. Although our findings suggest that recent infection with M. tuberculosis led to TST conversion in some children, the increase in follow-up TST induration could also be attributed to TST boosting resulting from prior BCG vaccination. When serial TST testing is completed in young, BCG-vaccinated children, interpretation of the follow-up TST should consider baseline TST results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776820     DOI: 10.1097/INF.0b013e3181758187

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

1.  Low Prevalence of Tuberculin Skin Test Boosting among Community Residents in Uganda.

Authors:  Juliet N Sekandi; Sarah Zalwango; Allan K Nkwata; Leonardo Martinez; Robert Kakaire; Jane N Mutanga; Christopher C Whalen; Noah Kiwanuka
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

2.  Standardization and Prevalence of the Booster Phenomenon: Evaluation Using a Two-Step Skin Test with 43 kDa Glycoprotein in Individuals from an Endemic Region of Paracoccidioidomycosis.

Authors:  Ana Paula C Marques; Sandra Maria V L Oliveira; Grazielli R Rezende; Dayane A Melo; Sonia M Fernandes-Fitts; Elenir Rose J C Pontes; Maria da Glória Bonecini-Almeida; Zoilo P Camargo; Rinaldo P Mendes; Anamaria M M Paniago
Journal:  Mycopathologia       Date:  2017-06-23       Impact factor: 2.574

3.  Candida skin testing is a poor adjunct to tuberculin skin testing in international adoptees.

Authors:  Kee Thai Yeo; Xiaobei Zhu; H Lester Kirchner; A Desiree LaBeaud; Anna Mandalakas
Journal:  Pediatr Infect Dis J       Date:  2009-11       Impact factor: 2.129

Review 4.  Dermatologic conditions in internationally adopted children.

Authors:  Diane L Whitaker-Worth; Cheryl B Bayart; Julia Anderson Benedetti
Journal:  Int J Womens Dermatol       Date:  2015-03-02

5.  Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).

Authors:  Margret Johansson Gudjónsdóttir; Karsten Kötz; Ruth Stangebye Nielsen; Philip Wilmar; Sofia Olausson; Daniel Wallmyr; Birger Trollfors
Journal:  BMC Infect Dis       Date:  2016-10-06       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.